NCT02268539View on ClinicalTrials.gov

Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in Paroxysmal Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 1, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Paroxysmal Atrial Fibrillation
Interventions
PROCEDURE

ablation

Ablation ranging from 20-25 watts / 30-45 seconds

Trial Locations (1)

SS16 5NL

The Essex Cardiothoracic Centre, Basildon

All Listed Sponsors
collaborator

Anglia Ruskin University

OTHER

lead

Mid and South Essex NHS Foundation Trust

OTHER

NCT02268539 - Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in Paroxysmal Atrial Fibrillation | Biotech Hunter | Biotech Hunter